Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.80 |
| ▸ | DPP4 | P27487 | 1/20 | 0.71 |
| ▸ | CD38 | P28907 | 1/20 | 0.71 |
| ▸ | SLC28A3 | Q9HAS3 | 4/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | TYR | P14679 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | SLC5A1 | P13866 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL318115 | 0.99 | F2 (0.81) | F2DPP4CD38SLC28A3EPHX2 | |
| Hydrochloric Acid SCHEMBL31213251 | 0.94 | CD38 (0.80) | F2DPP4CD38SLC28A3EPHX2 | |
| Hydrochloric Acid SCHEMBL29894453 | 0.94 | CD38 (0.80) | F2DPP4CD38SLC28A3EPHX2 | |
| Hydrochloric Acid SCHEMBL29374214 | 0.94 | CD38 (0.80) | F2DPP4CD38SLC28A3EPHX2 | |
| Hydrochloric Acid SCHEMBL675415 | 0.94 | CD38 (0.80) | F2DPP4CD38SLC28A3EPHX2 | |
| Hydrochloric Acid SCHEMBL30540085 | 0.93 | F2 (0.73) | F2DPP4CD38SLC28A3EPHX2 | |
| SCHEMBL675416 | 0.93 | CD38 (0.81) | F2DPP4CD38SLC28A3EPHX2 | |
| SCHEMBL30185877 | 0.93 | CD38 (0.81) | F2DPP4CD38SLC28A3EPHX2 | |
| SCHEMBL29532883 | 0.92 | F2 (0.75) | F2DPP4CD38SLC28A3EPHX2 | |
| Hydrochloric Acid SCHEMBL316878 | 0.90 | F2 (0.71) | F2DPP4CD38SLC28A3EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 799 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109960833-B | Method and system for optimizing direct-current distribution voltage class configuration scheme | 中国电力科学研究院有限公司 | 2024-07-16 | — | — | CN | claimed |
| US-12011496-B2 | Topical macqui berry formulation | Tracie Martyn International, Inc. (US) | 2024-06-18 | — | — | US | claimed |
| CN-117749309-A | Multi-channel message time synchronization method, system and vehicle | 深圳海星智驾科技有限公司 | 2024-03-22 | — | — | CN | claimed |
| US-20240010998-A1 | FLAVONE 4'-O-METHYLTRANSFERASE GENE AND USE FOR SAME | SUNTORY HOLDINGS LIMITED (JP) | 2024-01-11 | — | — | US | claimed |
| WO-2023219526-A1 | MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT | PROKIN MILAN (RS) | 2023-11-16 | — | — | WO | claimed |
| US-20230355769-A1 | COMPOSITIONS, CONTAINERS, AND METHODS RELATED TO FLAVYLIUM EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2023-11-09 | — | — | US | claimed |
| US-20230338331-A1 | COMPOSITIONS, CONTAINERS, AND METHODS RELATED TO FLAVYLIUM EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2023-10-26 | — | — | US | claimed |
| EP-4249597-A1 | FLAVONE 4'-O-METHYLTRANSFERASE GENE AND USE FOR SAME | Suntory Holdings Limited (JP) | 2023-09-27 | — | — | EP | claimed |
| CN-116634860-A | Flavone 4' -O-methyltransferase gene and application thereof | 三得利控股株式会社 | 2023-08-22 | — | — | CN | claimed |
| CN-218350740-U | Novel bathroom accessory based on intelligence AI pronunciation | 深圳市梦想智能物联有限公司 | 2023-01-20 | — | — | CN | claimed |
| EP-1478753-A4 | GENETIC SEQUENCES HAVING METHYLTRANSFERASE ACTIVITY AND USES THEREFOR | INTERNAT FLOWERS DEVELOPMENTS (AU) | 2007-03-28 | — | — | EP | claimed |
| EP-1478753-A1 | GENETIC SEQUENCES HAVING METHYLTRANSFERASE ACTIVITY AND USES THEREFOR | INTERNATIONAL FLOWER DEVELOPMENTS Pty. Ltd. (AU) | 2004-11-24 | — | — | EP | claimed |
| WO-2003062428-A1 | GENETIC SEQUENCES HAVING METHYLTRANSFERASE ACTIVITY AND USES THEREFOR | INTERNATIONAL FLOWER DEVELOPMENTS PTY LTD (AU) | 2003-07-31 | — | — | WO | claimed |
| WO-1997048404-A1 | WATER-SOLUBLE ORGAN EXTRACTS WITH IMPROVED BIOCHEMICAL EFFECTIVENESS, METHOD FOR PRODUCTION AND USE THEREOF | RIEMSCHNEIDER RANDOLPH (DE) | 1997-12-24 | — | — | WO | claimed |
| EP-0496349-B1 | Coating solution for preventing adhesion of polymer scale and method for its use | SHINETSU CHEMICAL CO (JP) | 1996-04-10 | — | — | EP | claimed |
| WO-1993024190-A1 | MUSCLE TRAINING DEVICE | PROMOTECH CORPORATION (LI) | 1993-12-09 | — | — | WO | claimed |
| EP-0496349-A1 | Coating solution for preventing adhesion of polymer scale and method for its use | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1992-07-29 | — | — | EP | claimed |
| EP-0284014-B1 | CONSTRUCTION SYSTEM FOR HEELING THE MAST OF SAILING BOATS TO WINDWARD | Haigis, Erich, Dr. (CH) | 1991-06-26 | — | — | EP | claimed |
| EP-0304585-A1 | Sporting device | Küttenbaum, Valentin (DE) | 1989-03-01 | — | — | EP | claimed |
| EP-0284014-A1 | Construction system for heeling the mast of sailing boats to windward | Haigis, Erich, Dr. (CH) | 1988-09-28 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230355769-A1 | COMPOSITIONS, CONTAINERS, AND METHODS RELATED TO FLAVYLIUM EXCIPIENTS | CNR2, CNR1, UGT8 | F2 50/4885DPP4 4789/4885CD38 2308/4885 |
| US-20230338331-A1 | COMPOSITIONS, CONTAINERS, AND METHODS RELATED TO FLAVYLIUM EXCIPIENTS | CNR2, CNR1, UGT8 | F2 50/4885DPP4 4789/4885CD38 2308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.